Yaxuan Li

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

FcμR enhances recall responses by promoting the generation of CD80+PD-L2+ memory B cells.

FcμR enhances recall responses by promoting the generation of CD80+PD-L2+ memory B cells.

Journal: International immunology
Published: December 13, 2025

FcµR and IgM-Mediated Complement Activation Cooperate to Enhance Humoral Immunity.

FcµR and IgM-Mediated Complement Activation Cooperate to Enhance Humoral Immunity.

Journal: European journal of immunology
Published: May 31, 2025

Neutrophil immaturity and ELANE mislocalization impair NETosis in ELANE-associated neutropenia.

Neutrophil immaturity and ELANE mislocalization impair NETosis in ELANE-associated neutropenia.

Journal: The Journal of allergy and clinical immunology
Published: May 20, 2025

A Novel R140S γc Variant Alters Cellular Distribution, Reduces Surface Expression, and Impairs Cytokine Signaling in Atypical X-SCID.

A Novel R140S γc Variant Alters Cellular Distribution, Reduces Surface Expression, and Impairs Cytokine Signaling in Atypical X-SCID.

Journal: Journal of clinical immunology
Published: January 13, 2025

Intrinsic functional defects in B cells of patients with NFKB2 mutations.

Intrinsic functional defects in B cells of patients with NFKB2 mutations.

Journal: Clinical and experimental immunology
Published: May 21, 2024

Impact of different genetic mutations on granulocyte development and G-CSF responsiveness in congenital neutropenia.

Impact of different genetic mutations on granulocyte development and G-CSF responsiveness in congenital neutropenia.

Journal: Blood advances
Published: November 13, 2023

B cell abnormalities and autoantibody production in patients with partial RAG deficiency.

B cell abnormalities and autoantibody production in patients with partial RAG deficiency.

Journal: Frontiers in immunology
Published: January 31, 2023

Protocol for an open-label, single-arm, multicentre clinical study to evaluate the efficacy and safety of rituximab in the first episode of paediatric idiopathic nephrotic syndrome.

Protocol for an open-label, single-arm, multicentre clinical study to evaluate the efficacy and safety of rituximab in the first episode of paediatric idiopathic nephrotic syndrome.

Journal: BMJ open
Published: October 12, 2022

LAPTM5 mediates immature B cell apoptosis and B cell tolerance by regulating the WWP2-PTEN-AKT pathway.

LAPTM5 mediates immature B cell apoptosis and B cell tolerance by regulating the WWP2-PTEN-AKT pathway.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 29, 2022

RAG1 splicing mutation causes enhanced B cell differentiation and autoantibody production.

RAG1 splicing mutation causes enhanced B cell differentiation and autoantibody production.

Journal: JCI insight
Published: February 19, 2021
Showing 1-10 of 10

Last Updated: 09/26/2026